Peer Briken1, Martin P Kafka. 1. Institute for Sex Research and Forensic Psychiatry, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. briken@uke.uni-hamburg.de
Abstract
PURPOSE OF REVIEW: This review addresses testosterone-lowering and other psychotropic medications for the treatment of paraphilic patients or sexual offenders. RECENT FINDINGS: Randomized controlled studies are still lacking, and only a few new studies were reported during the past year. On the other hand, there is substantial scientific knowledge about the wide range of psychiatric comorbidity associated with paraphilias and in sexual offenders. Empirically based treatment of these patients, especially of impulsivity, anxiety and mood disorders, may also ameliorate sexual impulsivity. SUMMARY: Medication interventions, either substantially lowering serum testosterone or treating axis I comorbidities, show definite promise as a significant component of the management of sexual offenders. Pharmacotherapy should be combined with other therapeutic treatment modalities, most commonly cognitive-behaviour based psychotherapy and intensive community supervision.
PURPOSE OF REVIEW: This review addresses testosterone-lowering and other psychotropic medications for the treatment of paraphilicpatients or sexual offenders. RECENT FINDINGS: Randomized controlled studies are still lacking, and only a few new studies were reported during the past year. On the other hand, there is substantial scientific knowledge about the wide range of psychiatric comorbidity associated with paraphilias and in sexual offenders. Empirically based treatment of these patients, especially of impulsivity, anxiety and mood disorders, may also ameliorate sexual impulsivity. SUMMARY: Medication interventions, either substantially lowering serum testosterone or treating axis I comorbidities, show definite promise as a significant component of the management of sexual offenders. Pharmacotherapy should be combined with other therapeutic treatment modalities, most commonly cognitive-behaviour based psychotherapy and intensive community supervision.
Authors: J L Müller; N Saimeh; P Briken; S Eucker; K Hoffmann; M Koller; T Wolf; M Dudeck; C Hartl; A-K Jakovljevic; V Klein; G Knecht; R Müller-Isberner; J Muysers; K Schiltz; D Seifert; A Simon; H Steinböck; W Stuckmann; W Weissbeck; C Wiesemann; R Zeidler Journal: Nervenarzt Date: 2017-08 Impact factor: 1.214
Authors: Kirsten Jordan; Peter Fromberger; Helge Laubinger; Peter Dechent; Jürgen L Müller Journal: BMC Psychiatry Date: 2014-05-17 Impact factor: 3.630